Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. [electronic resource]
Producer: 20011011Description: 449-54 p. digitalISSN:- 0091-6749
- Adult
- Anti-Allergic Agents -- therapeutic use
- Conjunctiva -- chemistry
- Conjunctivitis, Allergic -- drug therapy
- E-Selectin -- analysis
- Female
- Histamine -- analysis
- Histamine H1 Antagonists -- therapeutic use
- Humans
- Intercellular Adhesion Molecule-1 -- analysis
- Lolium -- adverse effects
- Male
- Middle Aged
- Nedocromil -- therapeutic use
- Piperidines -- therapeutic use
- Prostaglandin D2 -- analysis
- Tears -- chemistry
- Vascular Cell Adhesion Molecule-1 -- analysis
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.